A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma

Stage II and III Esophageal Squamous Cell Carcinoma Clinical Trial

Official title: A Phase II Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to determine whether docetaxel, cisplatin, and capecitabine (DCX) are effective as the neoadjuvant chemotherapy before esophagectomy in patients with loco-regional esophageal squamous cell carcinoma (ESCC).

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Carcinoma
• Carcinoma, Squamous Cell
• Esophageal Neoplasms
• Stage II and III Esophageal Squamous Cell Carcinoma

• NCT number: NCT02915965
• Study type: Interventional
• Source: Sun Yat-sen University
• Contact: Yanhong Deng, MD PHD
• Phone: +86020 38379762
• Email: dengyanh@mail.sysu.edu.cn
• Status: Not yet recruiting
• Phase: Phase 2
• Start date: October 2016